ClinTec has an impressive 11 years of experience working in the emerging market of Central and Eastern Europe with our regional office based in Krakow, Poland. 

Over the period that ClinTec has been operating in Central and Eastern Europe, we have conducted over 70 studies across a wide range of therapeutic areas; including Gastrointestinal diseases, Endocrine disorders, Oncology, Blood clotting disorders and Neurological conditions.

Our Regional Management team and local personnel are ideally located to provide the support required to perform a clinical study in this region, and can advise on Regulatory and Ethics submissions, Import of study drug, cultural considerations and language requirements, which will vary between countries.

Our global footprint in Central & Eastern Europe extends to:

Bulgaria / Croatia / Czech Republic / Greece / Hungary / Israel / Poland / Romania / Russia / Serbia / Slovakia / Slovenia


Why should you conduct studies in Central and Eastern Europe?

High quality healthcare standards, comparable to Western Europe and the USA and a dense network of healthcare facilities

Consistently high recruitment rates throughout the region

English-speaking investigators in a dense network of healthcare facilities.

Multi-specialty medical institutions (grouped departments, large geographical areas covered, high recruitment potential)